Phencyclidine: From medical innovation to a declining hallucinogen

pharmanewsdaily- February 23, 2025 0

Phencyclidine, once developed as an intravenous anaesthetic, quickly fell out of medical use due to its unpredictable and often severe psychological effects. While originally intended ... Read More

Mental stimulation may reduce Alzheimer’s risk, study suggests

pharmanewsdaily- February 9, 2025 0

As people age, it is common to experience subtle changes in memory and cognitive function. Forgetting familiar names, struggling to recall recent events, or having ... Read More

Understanding Depression Symptoms, Types, and Implications

pharmanewsdaily- June 15, 2024 0

Depression is a pervasive psychiatric condition recognized as a leading cause of disability worldwide. It spans a spectrum from mild depressive symptoms to severe cases ... Read More

Huntington’s Disease : Understanding Its Impacts and Treatments

pharmanewsdaily- June 15, 2024 0

Huntington's disease is a severe neurodegenerative disorder, characterized by its autosomal dominant inheritance pattern. This condition leads to progressive brain degeneration starting in adulthood, resulting ... Read More

Unveiling Vigabatrin: A groundbreaking antiepileptic drug

pharmanewsdaily- June 1, 2024 0

In the realm of neurological disorders, epilepsy has long posed significant challenges due to its complex nature and the difficulty in managing its symptoms. Vigabatrin ... Read More